Dr. Thompson was co-director of the center’s melanoma clinic and has led the Fred Hutch Phase 1 Clinical Trials program since 2008, according to a Dec. 19 news release from the center.
He was also a professor in the center’s clinical research division and in the division of hematology and oncology at Seattle-based University of Washington School of Medicine.
After joining Fred Hutch in 1985, Dr. Thompson was among a group of investigators who focused on testing new immunotherapy treatments, laying the groundwork for treatments seen today, the release said.
At the Becker's Perioperative Summit, taking place October 29–31 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
